Under construction – not a live service
Sign in
Taking people in El SalvadorNo phase

Heat treatment for cervical pre-cancer in women with HPV infection

Tests a thermal ablation device for cervical pre-cancer in HPV-positive women.

Plain-language title generated from the registry record
Registry title: Point of Care - Triage and Treatment for Cervical Pre-cancer

Key facts

Where
San Salvador, El SalvadorSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 49 years old?

Source: NCT07461818, who can take part

Where in El Salvador

  • Basic Health InternationalSan Salvador, El SalvadorTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Basic Health International, Inc.
Trial code
NCT07461818
Record updated
28 August 2026
Original description
This study evaluates a modified two-probe thermal ablation protocol using the IRIS™ device and retrospectively assesses an AI-based Automated Visual Evaluation (AVE) triage algorithm among HPV-positive women in El Salvador. The primary objective is to estimate 1-year cure rates of CIN2+ following treatment. A secondary objective is to evaluate the diagnostic performance of AVE compared with histopathology.Read full original descriptionShow less

POINT of CARE - Providing an Innovative New Triage and Treatment Strategy for Cervical Cancer Screening Efficiency

This study evaluates a modified two-probe thermal ablation protocol using the IRIS™ device and retrospectively assesses an AI-based Automated Visual Evaluation (AVE) triage algorithm among HPV-positive women in El Salvador. The primary objective is to estimate 1-year cure rates of CIN2+ following treatment. A secondary objective is to evaluate the diagnostic performance of AVE compared with histopathology.

Inclusion: Women aged 30-49 years; Non-pregnant (determined by urine pregnancy test); HPV-positive per Ministry of Health (MOH) records; Willing to undergo colposcopy and biopsies; Able and willing to provide informed consent.

Exclusion: History of LEEP or cervical ablation procedure in the past 5 years; History of total hysterectomy (verified by medical record or pelvic evaluation); History of cervical cancer; Plans to become pregnant during the study; Unable or unwilling to provide a permanent and reliable address; Unable or unwilling to provide informed consent.

ClinicalTrials.gov NCT07461818